Korro Bio (KRRO) Accounts Payables (2018 - 2026)

Korro Bio (KRRO) has reported Accounts Payables for 9 consecutive years, with $3.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables fell 30.21% year-over-year to $3.6 million; the trailing twelve-month figure through Jun 2026 stood at $3.6 million (down 30.21% YoY), and the FY2025 full-year result was $1.7 million, down 58.64% from the prior year.
• Accounts Payables improved to $3.6 million in Q2 2026 per KRRO's latest filing, from $2.0 million in the prior quarter.
• Across five years, Accounts Payables topped out at $7.3 million in Q4 2023 and bottomed at $338000.0 in Q3 2023.
• Historically, Accounts Payables has averaged $3.5 million across 5 years, with a median of $3.6 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Accounts Payables sank 91.57% in 2023, then surged 1660.36% in 2024.
• Over 5 years, Accounts Payables stood at $2.6 million in 2022, then surged by 179.46% to $7.3 million in 2023, then sank by 45.16% to $4.0 million in 2024, then tumbled by 58.64% to $1.7 million in 2025, then soared by 118.23% to $3.6 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $3.6 million, $2.0 million, and $1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.